Zivo Bioscience Inc - Warrants (29/04/2026)
ZIVOW
Get informed when a big investor buys or sells
+ FollowMarket Cap$182.63K
Close$
$0.09
99.1% upside
Current Fair Value
99.1% upsideUndervalued by 99.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $182,633.00 |
|---|---|
| Enterprise Value | $638,494.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.59 |
| Beta | 0.06 |
| Outstanding Shares | 4,150,756 |
Return
| Return on Equity | 162.76% |
|---|---|
| Return on Assets | -1241.30% |
| Return on Invested Capital | 162.52% |
Valuation & Multiples
| P/E Ratio | -4.46 |
|---|---|
| PEG | 6.49 |
| Price to Sales | - |
| Price to Book Ratio | -0.04 |
| Enterprise Value to Revenue | 9.73 |
| Enterprise Value to EBIT | -0.12 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.89 |
| Debt to Equity | -0.17 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Zivo Bioscience Inc
8 employees
CEO: Andrew Dahl